The ρ-kinase inhibitors Y-27632 and fasudil act synergistically with imatinib to inhibit the expansion of ex vivo CD34+ CML progenitor cells

Specificity and mechanism of action of some commonly used protein kinase inhibitors

Stephen Davies, Helen Reddy, Matilde Caivano et al. · Biochemical Journal · 2000 · 4.1K citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Specificity and mechanism of action of some commonly used protein kinase inhibitors

Stephen Davies, Helen Reddy, Matilde Caivano et al. · Biochemical Journal · 2000 · 3.1K citations

Medicine, Medicinal Chemistry, Pharmacology +13

The Tyrosine Kinase Inhibitor CGP57148B Selectively Inhibits the Growth of BCR-ABL–Positive Cells

Michael W. Deininger, John M. Goldman, Nicholas Lydon et al. · Blood · 1997 · 626 citations

Life Sciences, Oncology, Pharmacology +10

Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment

Ravi Bhatia, Melissa Holtz, Ning Niu et al. · Blood · 2003 · 541 citations · Full text

Medicine, Hematology, Oncology +15

Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia

A Bedi, BA Zehnbauer, SJ Sharkis et al. · Blood · 1994 · 498 citations · Full text

Medicine, Cancer Biology, Oncology +12